| Can a memory loss drug already on the market prevent Alzheimer’s disease? Study in the works WOIO: Alan Lerner, professor of neurology at the School of Medicine, discussed a university study that he’s heading to find out whether a drug already on the market could help prevent Alzheimer’s disease decades before it even shows up in patients prone to the disease. |
A new machine learning program developed by researchers at Case Western Reserve University integrates a range of Alzheimer’s disease indicators. In two stages, the program selects the most pertinent, outperforming other methods used for early diagnosis.